Urine 8-isoprostane in relation to adiposity and insulin resistance in individuals at high cardiometabolic risk

Metabolic Syndrome and Related Disorders

Volumn 13, Issue 4, 2015, Pages 187-191

  Costabile, Giuseppina ^a,b   Della Pepa, Giuseppe ^a   Bozzetto, Lutgarda ^a   Annuzzi, Giovanni ^a   Vetrani, Claudia ^a   Giacco, Rosalba ^b   Della Corte, Giuseppina ^a   Conte, Francesca Serena ^a   Di Marino, Lucrezia ^a   Rivellese, Angela Albarosa ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOPROSTANE DERIVATIVE; TRIACYLGLYCEROL; 8-EPI-PROSTAGLANDIN F2ALPHA; PROSTAGLANDIN F2 ALPHA;

8 ISOPROSTANE URINE LEVEL; ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DOWN REGULATION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; URINE LEVEL; WAIST CIRCUMFERENCE; WEIGHT GAIN; ABDOMINAL FAT; AGE; ANALOGS AND DERIVATIVES; BLOOD; BODY WEIGHT; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK ASSESSMENT; SEXUAL DEVELOPMENT; URINE;

ABDOMINAL FAT; ADIPOSITY; ADULT; AGE FACTORS; AGED; BODY WEIGHT; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DINOPROST; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; OXIDATIVE STRESS; RISK ASSESSMENT; SEX CHARACTERISTICS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84928527374     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2014.0119     Document Type: Article

References (26)

1. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009; 202: 321-329
2. Hopps E, Noto D, Cami G, Averna MR. A novel component of the metabolic syndrome: The oxidative stress. Nutr Metab Cardiovasc Dis 2010; 20: 72-77
3. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74: 139-162
4. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br J Pharmacol 2004; 142: 231-255
5. Dalle-Donne I, Rossi R, Colombo R, et al. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 601-623
6. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: Markers and mediators of oxidative stress. FASEB J 2004; 18: 1791-1800
7. Morrow JD. Quantification of isoprostanes as indices of oxidant stress and risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005; 25: 279-286
8. Minuz P, Fava C, Lechi A. Lipid peroxidation, isoprostanes and vascular damage. Pharmacol Rep 2006; 58(Suppl): 57-68
9. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 2006; 30: 400-418
10. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23: 434-439
11. Il'yasova D, Wang F, Spasojevic I, et al. Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort. Obesity (Silver Spring) 2012; 20: 1915-1921
12. Gopaul NK, Manraj MD, Hebe A, et al. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 2001; 44: 706-712
13. Yesilova Z, Yaman H, Oktenli C, et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease.AmJGastroenterol 2005; 100: 850-855
14. Meigs JB, Larson MG, Fox CS, et al. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes. The Framingham Offspring Study. Diabetes Care 2007; 30: 2529-2535
15. D'Archivio M, Annuzzi G, Vari R, et al. Predominant role of obesity/insulin resistance in oxidative stress development. Eur J Clin Invest 2012; 42: 70-78
16. Shin MJ, Lee JH, Jang Y, et al. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: Leptin as an 8-epi-prostaglandin F2 alpha determinant. Metabolism 2006; 55: 918-922
17. Sjogren P, Basu S, Rosell M, et al. Measures of oxidized lowdensity lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arterioscler Thromb Vasc Biol 2005; 25: 2580-2586
18. Boyne MS, Sargeant LA, Bennett FI, et al. Isoprostanes, a marker of lipid peroxidation, may not be involved in the development of glucose intolerance. Diabetes Res Clin Pract 2007; 76: 149-151
19. Il'yasova D, Morrow JD, Wagenknecht LE. Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes. Obes Res 2005; 13: 1638-1644
20. Giacco R, Costabile G, Della Pepa G, et al. A whole-grain cereal-based diet lowers postprandial plasma insulin and triglyceride levels in individuals with metabolic syndrome. Nutr Metab Cardiovasc Dis 2014; 24: 837-844
21. Annuzzi G, Bozzetto L, Costabile G, et al. Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: A randomized controlled trial. Am J Clin Nutr 2014; 99: 463-471
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421
23. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 2003; 17: 305-322
24. Davì G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002; 288: 2008-2014
25. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761
26. Proudfoot J1, Barden A, Mori TA, et al. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 1999; 272: 209-215